ZIOPHARM, Inc. Elects George B. Abercrombie, former CEO of Hoffmann-La Roche AG, to Board of Directors

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today the appointment of George B. Abercrombie to its Board of Directors. Mr. Abercrombie will serve as a member of the Board’s Compensation Committee as well as the Nominating and Corporate Governance Committee. Additionally, Dr. Murray Brennan was elected Chairman of the Board.

Back to news